|
Volumn 1, Issue 1, 1999, Pages 31-34
|
Is there a common mechanism of benefit for effective treatment of heart failure?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATRIAL NATRIURETIC FACTOR;
BRAIN NATRIURETIC PEPTIDE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
NORADRENALIN;
EDITORIAL;
HEART DILATATION;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FUNCTION;
HEART LEFT VENTRICLE WALL MOTION;
HEART VENTRICLE ARRHYTHMIA;
HEART VENTRICLE TACHYCARDIA;
HOLTER MONITORING;
HUMAN;
NATRIURESIS;
NEUROENDOCRINE SYSTEM;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PLASMA RENIN ACTIVITY;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SCINTIANGIOGRAPHY;
SODIUM RETENTION;
STRUCTURE ANALYSIS;
VASOCONSTRICTION;
VASODILATATION;
ATRIAL NATRIURETIC FACTOR;
ELECTROCARDIOGRAPHY, AMBULATORY;
HEART FAILURE, CONGESTIVE;
HUMANS;
NATRIURETIC PEPTIDE, BRAIN;
TACHYCARDIA, VENTRICULAR;
VENTRICULAR FUNCTION, LEFT;
|
EID: 0033370546
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(99)00002-1 Document Type: Editorial |
Times cited : (4)
|
References (20)
|